Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DERMALA's topical probiotic skincare formulation, specifically the OAT So Sweet Daily Moisturizer, is designed to treat acne while addressing skin irritation and dryness. It utilizes the patented SE Microbiome Complex®, a proprietary blend of prebiotics and postbiotics derived from *Staphylococcus epidermidis*. This complex works by selectively inhibiting the growth of *Cutibacterium acnes* (the primary bacteria associated with acne) while supporting the growth of beneficial skin bacteria to restore microbiome balance. The formulation also includes colloidal oatmeal to soothe irritation and provide hydration. It serves as a microbiome-friendly alternative to traditional acne treatments like benzoyl peroxide, which can be harsh and drying.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OAT So Sweet Daily Moisturizer.